Historical shareholding details of
Dr. Matthew Henn, PhD
holdings in Seres Therapeutics Inc (MCRB)
Monthly changes of
Dr. Matthew Henn, PhD
shareholding in Seres Therapeutics Inc
over the previous
months
|
Month
|
Name |
Total no. shares held |
Percent Holding |
|
Aug 18, 2025
|
Dr. Matthew Henn, Phd
|
4,548
|
0.01%
|
|
|
|
May 16, 2025
|
Dr. Matthew Henn, Phd
|
4,383
|
0.01%
|
|
|
|
Feb 18, 2025
|
Dr. Matthew Henn, Phd
|
84,443
|
0.12%
|
|
|
|
Nov 18, 2024
|
Dr. Matthew Henn, Phd
|
77,770
|
0.11%
|
|
|
|
Oct 28, 2024
|
Dr. Matthew Henn, Phd
|
75,885
|
0.11%
|
|
|
|
Aug 16, 2024
|
Dr. Matthew Henn, Phd
|
67,247
|
0.09%
|
|
|
|
May 15, 2024
|
Dr. Matthew Henn, Phd
|
65,357
|
0.09%
|
|
|
|
Feb 16, 2024
|
Dr. Matthew Henn, Phd
|
63,436
|
0.09%
|
|
|
|
Oct 30, 2023
|
Dr. Matthew Henn
|
56,356
|
0.08%
|
|
|
|
Jul 05, 2022
|
Dr. Matthew Henn
|
47,619
|
0.07%
|
View all ownership details of Seres Therapeutics Inc